Key facts
- It has raised $155.0M; the latest was Later Stage VC ($40.0M) in Sep 2024.
- Notable investors include Temasek Holdings, Deerfield Management, Aliment Capital, Corteva, Leaps by Bayer.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Pairwise
- ·The full record, as it builds
Funding rounds
No funding rounds for Pairwise are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pairwise
Developer of a genome-editing platform intended to make healthy eating more convenient and appealing. The company's consumer business develops differentiated fruits and vegetables that promote healthy dietary shifts along with taste, texture, convenience, nutrition, shelf life, waste mitigation, and features that improve the environmental footprint of agriculture, enabling farmers to concentrate on nutrition and ignore food challenges.
- Sector
- Materials and Resources
- HQ
- Durham, NC, United States
- Founded
- 2017
- Employees
- 108
- Website
- pairwise.com/
- Ownership
- Privately Held (backing)
Pairwise doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pairwise shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pairwise in its N-PORT filings yet. We sweep new filings monthly.